ATA Guidelines Tools

Thyroid Disease in Preconception, Pregnancy, and Postpartum

American Thyroid Association Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/1545288

Contents of this Issue

Navigation

Page 38 of 53

39 Examples Aplasia cutis Omphalocele Methimazole or carbimazole b Odds ratio 0.1 0.2 0.4 1 2 4 8 12 20 Musculoskeletal system Eye Integumentary system Digestive system Urinary system Respiratory system Circulatory system MMI/CMZ use only Both PTU and MMI/CMZ 8.1% (N=91/1,120) 8.0% (N=147/1,841) 9.1% (N=100/1,097) 10.1% (N=16/159) e relative and absolute risks, as well as examples of affected organ systems and severity of congenital malformations, associated with maternal antithyroid drug use during pregnancy are summarized from data reported in two large epidemiologic studies.

Articles in this issue

Archives of this issue

view archives of ATA Guidelines Tools - Thyroid Disease in Preconception, Pregnancy, and Postpartum